Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07765511

1 development in the corpus

NCT07765511

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 1 TRIAL

A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

ClinicalTrials.gov

Phase 1 safety and tolerability study in a planned enrollment of 60 participants; no results posted; designed to characterize adverse events and pharmacokinetics rather than efficacy.

PreliminaryMacupatide Eli Lilly and Company Obesity

Reported

Planned enrollment60

Study phasePhase 1

Primary endpointNumber of Participants with One or More Ser…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support